A study in humans identified the mir-4304 as a potential biomarker for recurrent myocardial infarction risk, where it was upregulated in whole blood of patients with recurrent MI compared to those without, with an FDR <0.1 in a replication cohort, though it was not significantly different in plasma samples [Onuoha et al. DOI:10.1111/cts.13307].